Verily Life Sciences
Michael V. McConnell, MD, MSEE is Head of Cardiovascular Health Innovations at Verily Life Sciences and Professor of Cardiovascular Medicine at Stanford School of Medicine, where he continues to see patients and teach in the Stanford Biodesign program. Dr. McConnell has clinical and research expertise in cardiovascular imaging, prevention, and mobile health. While at Stanford, he led the Cardiovascular MRI program, the Preventive Cardiology Clinic, and the MyHeart Counts cardiovascular mHealth ResearchKit study.
Dr. McConnell completed his BS and MS in EE/BioE at MIT, his MD at Stanford, and his Cardiovascular Medicine and Imaging Fellowships at Brigham and Women’s Hospital/Harvard Medical School. He has been the PI of multiple grants from the NIH and AHA, and is a Fellow of the AHA and ACC. He serves on the AHA’s Health Tech Advisory Board since its founding and is currently co-chair of AHA’s 2030 Goals Task Force. He also serves on the Physical Activity Standards working group for the Consumer Technology Association.